214 related articles for article (PubMed ID: 37723899)
1. Clinicopathological and circulating cell-free DNA profile in myositis associated with anti-mitochondrial antibody.
Wang Y; Zhao Y; Yu M; Wei L; Zhang W; Wang Z; Yuan Y
Ann Clin Transl Neurol; 2023 Nov; 10(11):2127-2138. PubMed ID: 37723899
[TBL] [Abstract][Full Text] [Related]
2. The clinical and histopathological features of idiopathic inflammatory myopathies with asymmetric muscle involvement.
Liu M; Hou Y; Dai T; Lv J; Li W; Zhao Y; Fang Q; Yan C
J Clin Neurosci; 2019 Jul; 65():46-53. PubMed ID: 31060889
[TBL] [Abstract][Full Text] [Related]
3. Muscle pathological features and extra-muscle involvement in idiopathic inflammatory myopathies with anti-mitochondrial antibody.
Zhang L; Yang H; Lei J; Peng Q; Yang H; Wang G; Lu X
Semin Arthritis Rheum; 2021 Aug; 51(4):741-748. PubMed ID: 34144384
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and diagnostic tools in idiopathic inflammatory myopathies.
Tsamis KI; Boutsoras C; Kaltsonoudis E; Pelechas E; Nikas IP; Simos YV; Voulgari PV; Sarmas I
Crit Rev Clin Lab Sci; 2022 Jun; 59(4):219-240. PubMed ID: 34767470
[TBL] [Abstract][Full Text] [Related]
5. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
Merlonghi G; Antonini G; Garibaldi M
Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
[TBL] [Abstract][Full Text] [Related]
6. Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy.
Lia A; Annese T; Fornaro M; Giannini M; D'Abbicco D; Errede M; Lorusso L; Amati A; Tampoia M; Trojano M; Virgintino D; Ribatti D; Serlenga L; Iannone F; Girolamo F
Rheumatology (Oxford); 2022 Aug; 61(8):3448-3460. PubMed ID: 34864921
[TBL] [Abstract][Full Text] [Related]
7. Murine models of idiopathic inflammatory myopathies.
Okiyama N; Konishi R; Ichimura Y
J Dermatol; 2024 Feb; ():. PubMed ID: 38321631
[TBL] [Abstract][Full Text] [Related]
8. Correlation of PMN elastase and PMN elastase-to-neutrophil ratio with disease activity in patients with myositis.
Wu S; Peng W; Zhang Y; Guo J; Fu J; Wang W
J Transl Med; 2019 Dec; 17(1):420. PubMed ID: 31842908
[TBL] [Abstract][Full Text] [Related]
9. Anti-mitochondrial antibodies in Indian patients with idiopathic inflammatory myopathies.
Gaur PS; R N; Anuja AK; Singh MK; Rai MK; Muhammed R; Sahu AK; Agarwal V; Gupta L
Int J Rheum Dis; 2022 Jun; 25(6):659-668. PubMed ID: 35384316
[TBL] [Abstract][Full Text] [Related]
10. Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.
Kohler C; Radpour R; Barekati Z; Asadollahi R; Bitzer J; Wight E; Bürki N; Diesch C; Holzgreve W; Zhong XY
Mol Cancer; 2009 Nov; 8():105. PubMed ID: 19922604
[TBL] [Abstract][Full Text] [Related]
11. [A unicenter real-world study of the correlation factors for complete clinical response in idiopathic inflammatory myopathies].
Lai Z; Li J; Yun Z; Zhang Y; Zhang H; Xing X; Shao M; Jin Y; Wang N; Li Y; Li Y; Li Z
Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 56(2):284-292. PubMed ID: 38595246
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and immunological characteristics of 88 cases of overlap myositis].
Xiao YS; Zhu FY; Luo L; Xing XY; Li YH; Zhang XW; Shen DH
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1088-1093. PubMed ID: 34916687
[TBL] [Abstract][Full Text] [Related]
13. Myocardial involvement in idiopathic inflammatory myopathies: a multi-center cross-sectional study in the CRDC-MYO Registry.
Zhang L; Zhu H; Yang P; Duan X; Wei W; Wu Z; Fang Y; Li Q; Liu S; Shi X; Li H; Wu C; Zhou S; Leng X; Zhao J; Xu D; Wu Q; Tian X; Li M; Zhao Y; Wang Q; Zeng X;
Clin Rheumatol; 2021 Nov; 40(11):4597-4608. PubMed ID: 34184155
[TBL] [Abstract][Full Text] [Related]
14. Contribution of Complement, Microangiopathy and Inflammation in Idiopathic Inflammatory Myopathies.
Honda M; Shimizu F; Sato R; Nakamori M
J Neuromuscul Dis; 2024; 11(1):5-16. PubMed ID: 38143369
[TBL] [Abstract][Full Text] [Related]
15. Murine models of idiopathic inflammatory myopathy.
Konishi R; Ichimura Y; Okiyama N
Immunol Med; 2023 Mar; 46(1):9-14. PubMed ID: 36282924
[TBL] [Abstract][Full Text] [Related]
16. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.
Basharat P; Christopher-Stine L
Curr Rheumatol Rep; 2015 Dec; 17(12):72. PubMed ID: 26515574
[TBL] [Abstract][Full Text] [Related]
17. Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis.
Sabbagh SE; Pinal-Fernandez I; Casal-Dominguez M; Albayda J; Paik JJ; Miller FW; Rider LG; Mammen AL; Christopher-Stine L;
Clin Rheumatol; 2021 Oct; 40(10):4095-4100. PubMed ID: 33851273
[TBL] [Abstract][Full Text] [Related]
18. Classification of idiopathic inflammatory myopathies: pathology perspectives.
Tanboon J; Nishino I
Curr Opin Neurol; 2019 Oct; 32(5):704-714. PubMed ID: 31369423
[TBL] [Abstract][Full Text] [Related]
19. Nailfold videocapillaroscopy alterations in dermatomyositis, antisynthetase syndrome, overlap myositis, and immune-mediated necrotizing myopathy.
Soubrier C; Seguier J; Di Costanzo MP; Ebbo M; Bernit E; Jean E; Veit V; Swiader L; Salort-Campana E; Attarian S; De Paula AM; Kaplanski G; Durand JM; Harlé JR; Schleinitz N
Clin Rheumatol; 2019 Dec; 38(12):3451-3458. PubMed ID: 31440919
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis.
Mandel DE; Malemud CJ; Askari AD
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28524083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
